Live Updates:

On | Off

  • REGENERON PHARMACEUTICALS Key Ratios

  • Valuation Ratio: REGN

    P/E (TTM) -28.45
    Price to CashFlow -83.32
    Price to Sales (TTM) 5.09
    Price to Book 4.94
  • Per Share Ratio: REGN

    Dividend Per Share (TTM) 0.00
    Book Value Per Share 4.89
    EPS Fully Diluted -0.85
    Revenue Per Share 4.75
  • 5 Year Annual Growth: REGN

    Net Income
    Revenue 16.86%
    Dividend Per Share (TTM) 0.00%
    EPS
  • Dividends: REGN

    Dividend Yield 0.00%
    Dividend Yield - 5 Yr. Avg. 0.00%
    Dividend Per Share (TTM) 0.00
    Dividend Payout Ratio 0.00
  • Profit Margins: REGN

    Operations Margin -19.54%
    Net Profit Margin -17.88%
    Gross Profit Margin -5.58%
  • Financial Strength: REGN

    Quick Ratio (MRQ) 4.35
    Current Ratio (MRQ) 4.55
    LT Debt to Equity (MRQ) 27.48
    Total Debt to Equity (MRQ) 27.48
    Return on Equity (ROE) Per Share -16.77
    Return on Assets (ROA) -9.40
    Return on Invested Capital (ROIC) -14.34
  • Assets: REGN

    Asset Turnover 0.51
    Inventory Turnover 89.96